Initial studies on the COVID-19 Omicron variant have shown that it could be less serious than the earlier strains. Additionally, vaccine manufacturers Pfizer and BioNTech have given assurances that three doses of their vaccine will “neutralize” the variant. The U.S. government has instituted stricter testing standards than the international ban on travel to address the surge in omicrons. According to us, prices for travel service stocks Travel + Leisure, (NASDAQ:) have risen significantly in the last few days and could rise further in the future. Continue reading. Nation’s around the world are dealing with COVID-19-induced uncertainty. The newly discovered omicron variant is threatening global economic recovery and public health. Early data from South Africa suggests that the variant may not cause severe symptoms. Additionally, initial lab testing of the Pfizer Inc. (NYSE)/ BioNTech Se (NASDAQ: ) vaccine show that only three doses would negate its danger.

The government has had to tighten travel restrictions in response. The U.S. government decided not to ban international travel but instead, it imposed stricter requirements on travelers. Furthermore, the World Travel & Tourism Council (WTTC) has predicted that the U.S.’ travel and tourism sector could grow by 35.6% year-over-year in 2021, with promising prospects for the coming year.

This backdrop suggests that we believe it may be prudent to invest in travel service stocks Travel + Leisure Co., Inc. (TNL) or TripAdvisor, Inc., Inc. (TRIP) due to their inherent strength.

Continue reading on StockNews